Cagrilintide is a synthetic long-acting amylin analogue studied for its potential role in appetite regulation and metabolic control. It is designed to mimic natural amylin activity, which is involved in signaling satiety and supporting glucose balance.

It is commonly examined in research focused on appetite suppression pathways, caloric intake regulation, fat metabolism support, improved glycemic control, and overall metabolic optimization. Cagrilintide may also be explored for its potential effects on sustained weight management models, energy balance, and cardiometabolic health support.

For research purposes only.